Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q1 2026 Earnings Call Transcript May 6, 2026
Mirum Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-13.43 EPS, expectations were $-0.4.
Operator: Good afternoon, and welcome to Mirum Pharmaceuticals, Inc. First Quarter 2026 earnings conference call. My name is Tracy, and I will be your operator today. All lines are currently in a listen-only mode, and there will be an opportunity for Q&A after management’s prepared remarks. I...
